Nonisotopic substrate for assaying both human zinc and NAD+-dependent histone deacetylases.
Histone deacetylases (HDACs) are involved in the regulation of transcription and their inhibitors are a promising class of new anticancer drugs. We have previously reported Boc(Ac)Lys-AMC, also termed MAL, as a fluorescent substrate for HDACs. Now we present a modification of MAL called Z-MAL that is characterized by an increased rate of conversion by histone deacetylases of classes I and II and the recently discovered sirtuins (histone deacetylases class III). MAL and Z-MAL are the first nonradioactive substrates for class III enzymes. The new substrate Z-MAL allows for shorter assay times in inhibitor screening and is applicable to diverse sources of deacetylase activity even with completely different catalytic mechanisms. Interestingly, MAL shows some relative preference toward class II, indicating that subtype selectivity in small-molecule HDAC substrates might be obtained.
Heltweg
Birgit
B
Department of Pharmaceutical and Medicinal Chemistry, Westfälische Wilhelms-Universität Münster, Hittorfstr. 58-62, Münster 48149, Germany.
Dequiedt
Franck
F
Verdin
Eric
E
Jung
Manfred
M
D000818:Animals; D006367:HeLa Cells; D006655:Histone Deacetylases / Q000032:analysis* / Q000302:isolation & purification / Q000378:metabolism; D006801:Humans; D007554:Isotopes; D008099:Liver / Q000201:enzymology; D015394:Molecular Structure; D009243:NAD / Q000378:metabolism*; D051381:Rats; D013329:Structure-Activity Relationship; D013379:Substrate Specificity; D015032:Zinc / Q000378:metabolism*
D007554:Isotopes; D009243:NAD; D006655:Histone Deacetylases; D015032:Zinc